Meg Tully

Meg Tully has a Masters of Biostatistics from the University of Melbourne and is currently undertaking a PhD specialising in novel antimalarial combination therapies to combat the ongoing threat of drug resistance. She is based in the Centre for Epidemiology and Biostatistics within the Melbourne School of Population and Global Health and supervised by Prof Julie Simpson, Dr David Price and Dr Rob Commons. Her research is currently focused on pharmacokinetic-pharmacodynamic modelling of the within-host dynamics of various malaria treatments.